Evidence map›Paper›PMID 20536564›Full record

ReviewImmunological reviews2010

Plasticity in programming of effector and memory CD8 T-cell formation.

Ramon Arens, Stephen P Schoenberger

Abstract readReview
In one paragraph

Review in Immunological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Cell cycle arrest enhances CD8Nature immunology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Gut · 2023
    Article
  19. Review
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ramon ArensLaboratory of Cellular Immunology, The La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Stephen P Schoenberger

Funding

TRAIL-mediated regulation of T help for CTLR01CA081261 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2000 to 2009
$2.7M
Programming of CD8+ T Cell Tolerance by B Cell APCR01AI076972 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2007 to 2011
$2.5M
NCI NIH HHS R01 CA081261NIAID NIH HHS R01 AI076972
6 · The paper itself

Abstract

CD8(+) T cells (also called cytotoxic T lymphocytes) play a major role in protective immunity against many infectious pathogens and can eradicate malignant cells. The path from naive precursor to effector and memory CD8(+) T-cell development begins with interactions between matured antigen-bearing dendritic cells (DCs) and antigen-specific naive T-cell clonal precursors. By integrating differences in antigenic, costimulatory, and inflammatory signals, a developmental program is established that governs many key parameters associated with the ensuing response, including the extent and magnitude of clonal expansion, the functional capacities of the effector cells, and the size of the memory pool that survives after the contraction phase. In this review, we discuss the multitude of signals that drive effector and memory CD8(+) T-cell differentiation and how the differences in the nature of these signals contribute to the diversity of CD8(+) T-cell responses.

Indexed as

Cell DifferentiationCell ProliferationCytotoxicity, ImmunologicImmunologic MemoryLymphocyte ActivationSignal TransductionAnimalsCD8-Positive T-LymphocytesCommunicable DiseasesEpigenesis, GeneticHumansInflammationNeoplasmsVaccinesVaccines

Identifiers

PMID20536564
PMCPMC2937176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.